Incyte Hits Five-Year Low After GSK Snags Approval For A New Jakafi Rival

GSK's Shingles Vaccine Shows 100% Efficacy in Over-50s China Trial

Pfizer maternal RSV vaccine gets FDA approval

Tylenol Litigation Could Be a Headache for Kenvue

CDC Recommends New Sanofi, AstraZeneca Shot to Prevent RSV in Babies

Moderna Vaccine Forecast Raises Hope, Worry

Pfizer Cuts Guidance in Face of 'Near-Term' Setbacks

GSK's Endometrial Cancer Treatment Gets Further FDA Approval

Pharma Giant GSK Beats Second-Quarter Goals On Growth In Vaccines, General Medicines

GSK PLC 2Q Net Pft GBP1.62B

GSK PLC 2Q Turnover Consensus Was GBP6.77B

GSK Says HIV Drug Recommended for Marketing Authorization in Europe

GSK Gonorrhoea Vaccine Candidate Gets FDA Fast-Track Designation

GSK Shingles Vaccine Shingrix Approved in Japan for Adults Over 18

GSK Surges After Settling First Zantac Case, But A 'Conveyor Belt' Of Claims Looms

GSK, Pfizer RSV Vaccines Get Tepid Endorsment

GSK Stock Climbs on Zantac Settlement

The British stock market has turned into a wasteland as pension funds recoil. Why U.S. funds may pull back, too.

GSK Says RSV Vaccine Arexvy Recommended by US Health Authorities

Next Vaccine You Should Get? U.S. Health Advisers Back RSV Shots